Outcome of high-dose cytarabine-based induction therapy followed by hematopoietic stem cell transplantation in acute myeloid leukemia: influence of karyotype-Reference-Cited by-同舟云学术

Outcome of high-dose cytarabine-based induction therapy followed by hematopoietic stem cell transplantation in acute myeloid leukemia: influence of karyotype

Published:2008-01 Issue:12 Volume:49 Page:2284-2290
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Sirohi Bhawna,Powles Ray,Singhal Seema,Smith Katy,Jones Robin L.,Saso Radovan,Kulkarni Samar,Treleaven Jennifer,Swansbury G. John,Potter Mike,Morgan Gareth,Mehta Jayesh

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.1080/10428190802474454

Reference21 articles.

1. Repetitive Cycles of High-Dose Cytarabine Benefit Patients With Acute Myeloid Leukemia and inv(16)(p13q22) or t(16;16)(p13;q22): Results from CALGB 8461

2. Intensive Postremission Chemotherapy in Adults with Acute Myeloid Leukemia

3. A randomized study of high-dose cytarabine in induction in acute myeloid leukemia [see comments]

4. A randomized investigation of high-dose versus standard-dose cytosine arabinoside with daunorubicin in patients with previously untreated acute myeloid leukemia: a Southwest Oncology Group study

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analyses of therapeutic effects using rludarabine and cytarabine on acute myeloid leukemia at different stages during treatment;The Chinese-German Journal of Clinical Oncology;2009-06

2. Can the influence of karyotype in acute myeloid leukemia be overcome by high-dose chemotherapy?;Leukemia & Lymphoma;2008-01